NIH-funded research Fellowship grant

Targeting a specific enzyme in bacteria to prevent tooth decay

Official title: Streptococcus mutans diadenylate cyclase: A promising target for preventing dental caries

Funded at University of Alabama at Birmingham · NIH-11125740 · Data updated 2026-11-12

This study is looking at a new way to help prevent cavities by targeting a specific enzyme in the bacteria that cause tooth decay, aiming to stop harmful plaque from forming while keeping the good bacteria in your mouth healthy.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUniversity of Alabama at Birmingham
NIH-funded
Lab location1 site (Birmingham, United States)
Project startJuly 1, 2021
Project endJune 30, 2025
Funding year2024
Award (this year)$54,774
NIH project number5F30DE030334-04
Project IDNIH-11125740 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals at high risk for dental caries, such as those with a history of cavities or poor oral hygiene.

Less likely to help

Patients who do not have issues with dental caries or those with severe oral health conditions unrelated to S. mutans may not benefit from this research.

What this research studies

This research focuses on developing a new treatment to prevent dental caries by targeting the enzyme diadenylate cyclase in Streptococcus mutans, a bacterium responsible for tooth decay. The approach aims to selectively inhibit the formation of harmful biofilms without disrupting the beneficial bacteria in the mouth. By understanding how this enzyme influences biofilm formation, the researchers hope to create a more effective therapy that preserves the oral microbiome while reducing the risk of cavities.

Why it matters

Potential benefit: If successful, this research could lead to more effective treatments for preventing dental caries, improving oral health for many patients.

How similar studies have gone: Previous research has shown promise in targeting bacterial enzymes to manage biofilm-related infections, indicating potential success for this novel approach.

Where this research is happening

  • University of Alabama at Birmingham
    Birmingham, United States
    Active

Researchers

  • Principal investigator: Rojas, Edwin M — University of Alabama at Birmingham
  • Study coordinator: Rojas, Edwin M

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.